[Clofazimine. Current status of therapy with clofazimine (Lampren) for leprosy, erythema leprosum , and other dermatoses after donation of the medicine to the WHO by Novartis].
Sunderkötter
C H
CH
Klinik für Dermatologie und Allergologie, Universitätsklinikum Ulm. cord.sunderkoetter@medizin.uni-ulm.de
Lan Ma
H
H
D002608:Charities; D002986:Clinical Trials as Topic; D002991:Clofazimine / Q000627:therapeutic use*; D004893:Erythema Nodosum / Q000188:drug therapy*; D005858:Germany; D006801:Humans; D007918:Leprosy / Q000188:drug therapy*; D012871:Skin Diseases / Q000188:drug therapy; D016896:Treatment Outcome; D014944:World Health Organization
D002991:Clofazimine